scholarly journals Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial

2016 ◽  
Vol 70 (5) ◽  
pp. 875-883 ◽  
Author(s):  
Christopher Parker ◽  
Steven E. Finkelstein ◽  
Jeff M. Michalski ◽  
Joe M. O'Sullivan ◽  
Øyvind Bruland ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Efficacy And Safety ◽  
Castration Resistant Prostate Cancer ◽  
Opioid Use ◽  
Phase 3 ◽  
Castration Resistant ◽  
Radium 223

scholarly journals Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients

Theranostics ◽  
2020 ◽  
Vol 10 (20) ◽  
pp. 9364-9377 ◽  
Author(s):  
Madhav Prasad Yadav ◽  
Sanjana Ballal ◽  
Ranjit Kumar Sahoo ◽  
Madhavi Tripathi ◽  
Amlesh Seth ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Efficacy And Safety ◽  
Castration Resistant Prostate Cancer ◽  
Targeted Alpha Therapy ◽  
Castration Resistant ◽  
Alpha Therapy

scholarly journals Radium-223 in metastatic castration-resistant prostate cancer (mCRPC): efficacy and safety in real-life experience

2017 ◽  
Vol 28 ◽  
pp. vi23-vi24
Author(s):  
S.E. Rebuzzi ◽  
A. Prelaj ◽  
C. Pozzi ◽  
C. Ferrara ◽  
V. Frantellizzi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Life Experience ◽  
Real Life ◽  
Efficacy And Safety ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Radium 223
Sign in / Sign up

Export Citation Format

Share Document